Back
Jaguar Health Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
18
JAGX
Jaguar Health
Last Price:
1.10
Seasonality Move:
-34.71%
Sell
25
ALNY
Alnylam Pharmaceuticals
Last Price:
265.13
Seasonality Move:
5.61%
Sell
18
Jaguar Health (JAGX)
is a Sell
Is Jaguar Health a Buy, Sell or Hold?
- The current Jaguar Health [JAGX] share price is $1.10. The Score for JAGX is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- JAGX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
25
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $265.27. The Score for ALNY is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JAGX Stock Price Chart
What is Jaguar Health's stock price today?
-
The Jaguar Health share price today is $1.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JAGX is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $265.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
JAGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 31.17 | Sell |
| Chaikin Money Flow: | -26984 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.1 - 1.2) | Sell |
| Bollinger Bands (100): | (-0.1 - 10.46) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 53.6 | Buy |
| Chaikin Money Flow: | 403934 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (256.2 - 277.22) | Sell |
| Bollinger Bands (100): | (158.9 - 265.08) | Buy |
JAGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.12 | Sell |
| 20-day SMA: | 1.15 | Sell |
| 50-day SMA: | 1.87 | Sell |
| 200-day SMA: | 6.4 | Sell |
| 8-day EMA: | 1.12 | Sell |
| 20-day EMA: | 1.2 | Sell |
| 50-day EMA: | 2.08 | Sell |
| 200-day EMA: | 38.07 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 256.17 | Buy |
| 20-day SMA: | 266.77 | Sell |
| 50-day SMA: | 258.27 | Buy |
| 200-day SMA: | 189.51 | Buy |
| 8-day EMA: | 260.57 | Buy |
| 20-day EMA: | 261.96 | Buy |
| 50-day EMA: | 250.03 | Buy |
| 200-day EMA: | 205.35 | Buy |
Jaguar Health Earnings Growth & JAGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $71.43 per share, an increase next quarter of $1.81 per share, an increase this year of $0.43 per share, and an increase next year of $2.79 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.
Jaguar Health Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||